NFE2L2 and cancer: This drug resistance was effectively counteracted by siRNA targeting NRF2 and was observed to be diminished in NRF2 knockout K-rasG12V transformed cells, confirming the protective role of NRF2 in shielding cancer cells from the effects of chemotherapeutic agents [80,89].